ClinicalTrials.Veeva

Menu

Role of Oral Glutathione in Skin Whitening

C

Chulalongkorn University

Status and phase

Completed
Phase 1

Conditions

Skin Whitening

Treatments

Drug: placebo
Drug: glutathione

Study type

Interventional

Funder types

Other

Identifiers

NCT01016080
COA840/2008

Details and patient eligibility

About

Oral and intravenous glutathione have been used widely to whiten the skin. The investigators tested this hypothesis by giving oral glutathione for 4 weeks to medical students.

Enrollment

60 patients

Sex

All

Ages

18 to 25 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Healthy medical students

Exclusion criteria

  • history of skin cancer, especially melanoma
  • consumption of any preparations containing glutathione within 1 month of enrollment
  • pigmentary disorders or any dermatoses

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

60 participants in 2 patient groups, including a placebo group

oral glutathione
Active Comparator group
Description:
glutathione, 500 mg, taken orally twice daily
Treatment:
Drug: glutathione
placebo capsules
Placebo Comparator group
Description:
identical-appearing placebo capsules
Treatment:
Drug: placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems